Viza Electronics, LLC v. Paradigm Clinical Research Institute, Inc.

CourtDistrict Court, W.D. North Carolina
DecidedJuly 15, 2024
Docket3:22-cv-00049
StatusUnknown

This text of Viza Electronics, LLC v. Paradigm Clinical Research Institute, Inc. (Viza Electronics, LLC v. Paradigm Clinical Research Institute, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. North Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Viza Electronics, LLC v. Paradigm Clinical Research Institute, Inc., (W.D.N.C. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF NORTH CAROLINA CHARLOTTE DIVISION CIVIL ACTION NO. 3:22-CV-049-DCK

VIZA ELECTRONICS, LLC, ) ) Plaintiff, ) ORDER ) v. ) ) PARADIGM CLINICAL RESEARCH ) INSTITUTE, INC., RAM DANDILLAYA, ) JUAN DE BORBON Y DE ROJAS, LEONEL ) A. HUNT, M.D., DAVID G. NG, M.D., and ) KEVIN T. HSU, ) ) Defendants. ) )

THIS MATTER IS BEFORE THE COURT on Defendants’ Motions To Dismiss (Document Nos. 63, 64, and 65), “Defendants’ Motion To Modify Scheduling Order...” (Document No. 73), “Plaintiff’s Motion For Summary Judgment...” (Document No. 79), and “Defendants’ Motion To Withdraw Admissions...” (Document No. 81). The parties have consented to Magistrate Judge jurisdiction pursuant to 28 U.S.C. § 636(c), and these motions are ripe for disposition. Having carefully considered the motions, the record, and applicable authority, the undersigned will grant the motions to dismiss, grant the motion to modify scheduling order, deny in part the motion for summary judgment, and grant the motion to withdraw admissions. I. BACKGROUND Viza Electronics, LLC (“Plaintiff” or “Viza”) initiated this action with the filing of a “Complaint And Demand For Jury Trial” (Document No. 1) (the “Complaint”) on February 4, 2022. The case was originally assigned to the Honorable Max O. Cogburn, Jr. as the presiding Judge, and to the undersigned as the referral Magistrate Judge. The Complaint brought claims against Defendants Paradigm Clinical Research Institute, Inc., Ram Dandillaya, M.D., and Juan De Borbon Y De Rojas. Defendants’ “...Motion To Dismiss Plaintiff’s Complaint...” (Document No. 15) pursuant to Fed.R.Civ.P. 12(b)(2) and (6) was filed on March 24, 2022. Following a motion hearing on August 15, 2022, Judge Cogburn issued an “Order” (Document No. 20) on September 23, 2022, denying Defendants’ “...Motion To Dismiss Plaintiff’s Complaint...” (Document No. 15). Judge Cogburn held that this Court has specific jurisdiction over Defendant Dandillaya, and found that Plaintiff had sufficiently alleged claims for: fraud,

unfair and deceptive trade practices (“UDTPA”), unjust enrichment, and conversion.1 (Document No. 20). On or about November 23, 2022, the parties consented to Magistrate Judge jurisdiction and this case was reassigned to the undersigned Magistrate Judge. See (Document Nos. 27, 28, and 30). The Court issued a “Case Management Order” (Document No. 29) on November 29, 2022. On July 10, 2023, the undersigned granted Plaintiff’s “Consent Motion To Allow Amendment Of Complaint And Amend Scheduling Order” (Document No. 49). (Document No. 50). The case deadlines were re-set as follows: mediation report – October 11, 2023; discovery completion – January 30, 2024; and dispositive motions – March 1, 2024. Id. This matter is

scheduled for the undersigned’s trial term beginning October 21, 2024. (Document No. 87).

1 Defendants did not seek to dismiss Plaintiff’s breach of contract claim. 2 Plaintiff’s “First Amended Complaint And Demand For Jury Trial” (Document No. 51) (the “Amended Complaint”) was then filed on July 14, 2023. The Amended Complaint asserts claims against Defendants Paradigm Clinical Research Institute, Inc. (“Paradigm”), Ram Dandillaya, M.D. (“Dandillaya”), Juan De Borbon Y De Rojas, a/k/a Jon Rojas (“Rojas”), Leonel A. Hunt, M.D. (“Hunt”), David G. Ng, M.D. (“Ng”), and Kevin T. Hsu (“Hsu”) (all together, “Defendants”). (Document No. 51). The crux of the Amended Complaint is that in or about March 2020, “[a]s the threat of the novel coronavirus COVID-19 gripped the world,” Defendants convinced Plaintiff through a “Letter of Introduction and other misrepresentations” to place “an order with Paradigm for 20 million masks, at a cost of $52,000,000” but failed to deliver as promised. (Document No. 51, p.

1). Despite an “upfront payment deposit of $26,000,000 to Paradigm [] no masks were ever delivered by Paradigm to Viza.” (Document No. 51, p. 2). Plaintiff alleges that Paradigm made payments of $56,062.50 each to individual Defendants Dandillaya, Rojas, Hunt, Ng, and Hsu “pursuant to Defendants’ finders’ fee agreement to split money derived from the sale of PPE.” (Document No. 51, p. 7). To date, Defendant Paradigm has provided a partial refund to Plaintiff of $23,550,000.00, leaving the “outstanding amount of the Deposit retained by Paradigm” at $2,450,000.00. (Document No. 51, pp. 2, 6-7). Plaintiff’s claims include: (1) Fraud in the Inducement (all Defendants); (2) Fraud/Constructive Fraud (all Defendants); (3) Civil Conspiracy (all Defendants); (4) Breach of

Contract (Paradigm, Dandillaya, Rojas); (5) Conversion (Paradigm, Dandillaya, Rojas); (6) Unjust Enrichment (Paradigm, Dandillaya, Rojas); and (7) Alter Ego / Piercing the Corporate Veil (Dandillaya and Rojas). (Document No. 51, pp. 7-15). Plaintiff seeks compensatory and punitive 3 damages, as well as attorneys’ fees and treble damages pursuant to N.C.Gen.Stat. § 75-1.1 et seq. (Document No. 51, p. 15). On September 1, 2023, Defendants De Rojas, Dandillaya, and Paradigm filed Answers to the Amended Complaint. (Document Nos. 60, 61, and 62). Soon thereafter, on September 18, 2023, Defendants Hunt, Ng, and Hsu filed the now pending Motions To Dismiss pursuant to Fed.R.Civ.P. 12(b)(2) and (6). (Document Nos. 63, 64, and 65). “Defendants’ Motion To Modify Scheduling Order To Extend Discovery Completion Deadline” (Document No. 73) was filed on January 30, 2024. Plaintiff then filed its “...Motion For Summary Judgment As To Defendants Paradigm Clinical Research Institute, Inc., Leonel A. Hunt, M.D., David S. Ng, M.D., and Kevin T. Hsu” (Document No. 79) on March 1, 2024.

Also pending before the Court is “Defendants’ Motion To Withdraw Admissions . . . And To Order Defendants’ Responses To Requests For Admissions Timely” (Document No. 81) on March 6, 2024. The pending motions have been fully briefed and are ripe for review and disposition. II. STANDARD OF REVIEW A party invoking federal court jurisdiction has the burden of establishing that personal jurisdiction exists over the defendant. New Wellington Fin. Corp. v. Flagship Resort Dev. Corp., 416 F.3d 290, 294 (4th Cir. 2005); Combs v. Bakker, 886 F.2d 673, 676 (4th Cir. 1989). When a court’s personal jurisdiction is properly challenged by a Rule 12(b)(2) motion, the jurisdictional question thus raised is one for the judge, with the burden on the plaintiff ultimately to prove the existence of a ground for jurisdiction by a preponderance of evidence. . . . [W]hen, as here, the court addresses the question on the basis only of motion papers, supporting legal memoranda and the relevant allegations of a complaint, the burden on the plaintiff is simply to make a prima facie showing of a sufficient jurisdictional 4 basis in order to survive the jurisdictional challenge. In considering a challenge on such a record, the court must construe all relevant pleading allegations in the light most favorable to the plaintiff, assume credibility, and draw the most favorable inferences for the existence of jurisdiction.

Combs, 886 F.2d at 676. (internal citations omitted). “Mere allegations of in personam jurisdiction are sufficient for a party to make a prima facie showing.” Barclays Leasing, Inc. v. National Business Systems, Inc., 750 F.Supp. 184, 186 (W.D.N.C. 1990).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Helicopteros Nacionales De Colombia, S. A. v. Hall
466 U.S. 408 (Supreme Court, 1984)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Stetser v. TAP Pharmaceutical Products Inc.
591 S.E.2d 572 (Court of Appeals of North Carolina, 2004)
Barclays Leasing, Inc. v. National Business Systems, Inc.
750 F. Supp. 184 (W.D. North Carolina, 1990)
Hanes Companies, Inc. v. Ronson
712 F. Supp. 1223 (M.D. North Carolina, 1988)
Boon Partners v. Advanced Financial Concepts, Inc.
917 F. Supp. 392 (E.D. North Carolina, 1996)
Webb v. K.R. Drenth Trucking, Inc.
780 F. Supp. 2d 409 (W.D. North Carolina, 2011)
General Latex & Chemical Corp. v. Phoenix Medical Technology, Inc.
765 F. Supp. 1246 (W.D. North Carolina, 1991)
Youming Jin v. Ministry of State Security
335 F. Supp. 2d 72 (District of Columbia, 2004)
ESAB Group, Inc. v. Centricut, Inc.
126 F.3d 617 (Fourth Circuit, 1997)
Christian Science Board of Directors v. Nolan
259 F.3d 209 (Fourth Circuit, 2001)
Pan-American Products & Holdings, LLC v. R.T.G. Furniture Corp.
825 F. Supp. 2d 664 (M.D. North Carolina, 2011)
McLaughlin v. McPhail
707 F.2d 800 (Fourth Circuit, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
Viza Electronics, LLC v. Paradigm Clinical Research Institute, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/viza-electronics-llc-v-paradigm-clinical-research-institute-inc-ncwd-2024.